Company Intelligence

1910

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

In this profile

Quick Facts

  • Founded 2019
  • Headquarters Boston, United States
  • Country United States
  • Industry AI in Healthcare
  • Company Type Growth
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

Why It Matters

Multimodal AI Platform for Modality Agnostic Drug Discovery™

Products

Recent Developments

  1. 2019 Company founded

    1910 was founded in 2019 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe